Skip to main content

Advertisement

SpringerLink
Log in

Bacteriocins: perspective for the development of novel anticancer drugs

  • Mini-Review
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

Antimicrobial peptides (AMPs) from prokaryotic source also known as bacteriocins are ribosomally synthesized by bacteria belonging to different eubacterial taxonomic branches. Most of these AMPs are low molecular weight cationic membrane active peptides that disrupt membrane by forming pores in target cell membranes resulting in cell death. While these peptides known to exhibit broad-spectrum antimicrobial activity, including antibacterial and antifungal, they displayed minimal cytotoxicity to the host cells. Their antimicrobial efficacy has been demonstrated in vivo using diverse animal infection models. Therefore, we have discussed some of the promising peptides for their ability towards potential therapeutic applications. Further, some of these bacteriocins have also been reported to exhibit significant biological activity against various types of cancer cells in different experimental studies. In fact, differential cytotoxicity towards cancer cells as compared to normal cells by certain bacteriocins directs for a much focused research to utilize these compounds as novel therapeutic agents. In this review, bacteriocins that demonstrated antitumor activity against diverse cancer cell lines have been discussed emphasizing their biochemical features, selectivity against extra targets and molecular mechanisms of action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Abdi-Ali A, Worobec EA, Deezagi A, Malekzadeh F (2004) Cytotoxic effects of pyocin S2 produced by Pseudomonas aeruginosa on the growth of three human cell lines. Can J Microbiol 50:375–381

    CAS  PubMed  Google Scholar 

  • Agarwal V, Metlitskaya A, Severinov K, Nair SK (2011) Structural basis for microcin C7 inactivation by the MccE acetyltransferase. J Biol Chem 286:21295–21303

    CAS  PubMed  PubMed Central  Google Scholar 

  • Agrawal N, Bettegowda C, Cheong I, Geschwind J-F, Drake CG, Hipkiss EL, Tatsumi M, Dang LH, Diaz LA, Pomper M, Abusedera M, Wahl RL, Kinzler KW, Zhou S, Huso DL, Vogelstein B (2004) Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci U S A 101:15172–15177

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ahmadi S, Ghollasi M, Hosseini HM (2017) The apoptotic impact of nisin as a potent bacteriocin on the colon cancer cells. Microb Pathog 111:193–197

    CAS  PubMed  Google Scholar 

  • Ahn J, Chen CY, Hayes RB (2012) Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Control 23:399–404

    PubMed  PubMed Central  Google Scholar 

  • Alexandroff AB, Jackson AM, O’Donnell M, James K (1999) BCG immunotherapy of bladder cancer: 20 years on. Lancet 353:1689–1694

    CAS  PubMed  Google Scholar 

  • Andersland K, Jølle GF, Sand O, Haug TM (2010) Peptide pheromone plantaricin a produced by Lactobacillus plantarum permeabilizes liver and kidney cells. J Membr Biol 235:121–129

    CAS  PubMed  Google Scholar 

  • Aranha C, Gupta S, Reddy KVR (2004) Contraceptive efficacy of antimicrobial peptide Nisin: in vitro and in vivo studies. Contraception 69:333–338

    CAS  PubMed  Google Scholar 

  • Arnold T, Zeth K, Linke D (2009) Structure and function of colicin S4, a colicin with a duplicated receptor-binding domain. J Biol Chem 284:6403–6413

    CAS  PubMed  PubMed Central  Google Scholar 

  • Aymerich T, Garriga M, Ylla J (2000) Application of enterocins as biopreservatives against Listeria innocua in meat products. J Food Prot 63:721–726

    CAS  PubMed  Google Scholar 

  • Baindara P, Chaudhry V, Mittal G, Liao LM, Matos CO, Khathri N, Franco OL, Patil PB, Korpole S (2015) Characterization of the antimicrobial peptide Penisin, a class Ia novel Lantibiotic from Paenibacillus sp. strain A3. Antimicob Agents Chemother 60:580–591

    PubMed  PubMed Central  Google Scholar 

  • Baindara P, Singh N, Ranjan M, Nallabelli N, Chaudhry V, Pathania GL, Sharma N, Kumar A, Patil PB, Korpole S (2016) Laterosporulin10: a novel defensin like class IId bacteriocin from Brevibacillus sp. strain SKDU10 with inhibitory activity against microbial pathogens. Microbiol 162:1286–1299

    CAS  Google Scholar 

  • Baindara P, Gautam A, Raghava GPS, Korpole S (2017a) Anticancer properties of a defensin like class IId bacteriocin Laterosporulin10. Sci Rep 19;7:46541. https://doi.org/10.1038/srep46541

  • Baindara P, Kapoor A, Korpole S, Grover V (2017b) Cysteine-rich low molecular weight antimicrobial peptides from Brevibacillus and related genera for biotechnological applications. World J Microbiol Biotechnol 33:124

    PubMed  Google Scholar 

  • Bastos MDCDF, Coutinho BG, Coelho MLV (2010) Lysostaphin: a staphylococcal bacteriolysin with potential clinical applications. Pharmaceuticals 3:1139–1161

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bevers EM, Comfurius P, van Rijn JL, Hemker HC, Zwaal RF (1982) Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 122:429–436

    CAS  PubMed  Google Scholar 

  • Bizzarri AR, Santini S, Coppari E, Bucciantini M, Di Agostino S, Yamada T, Beattie CW, Cannistraro S (2011) Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy. Int J Nanomedicine 6:3011–3019

    CAS  PubMed  PubMed Central  Google Scholar 

  • Brader P, Stritzker J, Riedl CC, Zanzonico P, Cai S, Burnazi EM, Ghani ER, Hricak H, Szalay AA, Fong Y, Blasberg R (2008) Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging. Clin Cancer Res 14:2295–2302

    CAS  PubMed  Google Scholar 

  • Brand M, de Kwaadsteniet M, Dicks LMT (2010) The ability of nisin F to control Staphylococcus aureus infection in the peritoneal cavity, as studied in mice. Lett Appl Microbiol 51:645–649

    CAS  PubMed  Google Scholar 

  • Braun V, Pilsl H, Groß P (1994) Colicins: structures, modes of action, transfer through membranes, and evolution. Arch Microbiol 161:199–206

    CAS  PubMed  Google Scholar 

  • Breukink E, Wiedemann I, van Kraaij C, Kuipers OP, Sahl H, de Kruijff B (1999) Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286:2361–2364

    CAS  PubMed  Google Scholar 

  • Burdick MD, Harris A, Reid CJ, Iwamura T, M A H (1997) Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines. J Biol Chem 272:24198–24202

    CAS  PubMed  Google Scholar 

  • Burton JP, Cowley S, Simon RR, McKinney J, Wescombe PA, Tagg JR (2011) Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study. Food Chem Toxicol 49:2356–2364

    CAS  PubMed  Google Scholar 

  • Campion A, Casey PG, Field D, Cotter PD, Hill C, Ross RP (2013) In vivo activity of nisin A and nisin V against Listeria monocytogenes in mice. BMC Microbiol 13:23

    CAS  PubMed  PubMed Central  Google Scholar 

  • Cao LT, Wu JQ, Xie F, Hu SH, Mo Y (2007) Efficacy of nisin in treatment of clinical mastitis in lactating dairy cows. J Dairy Sci 90:3980–3985

    CAS  PubMed  Google Scholar 

  • Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 72:3666–3670

    CAS  PubMed  PubMed Central  Google Scholar 

  • Cascales E, Buchanan SK, Duché D, Kleanthous C, Lloubès R, Postle K, Riley M, Slatin S, Cavard D (2007) Colicin biology. Microbiol Mol Biol Rev 71:158–229

    CAS  PubMed  PubMed Central  Google Scholar 

  • Castiglione F, Lazzarini A, Carrano L, Corti E, Ciciliato I, Gastaldo L, Candiani P, Losi D, Marinelli F, Selva E, Parenti F (2008) Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multi-resistant pathogens. Chem Biol 15:22–31

    CAS  PubMed  Google Scholar 

  • Chaudhari A, Mahfouz M, Fialho AM, Yamada T, Granja AT, Zhu Y, Hashimoto W, Schlarb-Ridley B, Cho W, Das Gupta TK, Chakrabarty AM (2007) Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth. Biochem 46:1799–1810

    CAS  Google Scholar 

  • Chaudhary J, Munshi M (1995) Scanning electron microscopic analysis of breast aspirates. Cytopathology 6:162–167

    CAS  PubMed  Google Scholar 

  • Chen H, Hoover DG (2003) Bacteriocins and their food applications. Compr Rev Food Sci Food Saf 2:82–100

    CAS  Google Scholar 

  • Chen Y-LS, Li J-H, Yu C-Y, Lin C-J, Chiu P-H, Chen P-W, Lin C-C, Chen W-J (2012) Novel cationic antimicrobial peptide GW-H1 induced caspase-dependent apoptosis of hepatocellular carcinoma cell lines. Peptides 36:257–265

    CAS  PubMed  Google Scholar 

  • Cho J, Hwang IS, Choi H, Hwang JH, Hwang JS, Lee DG (2012) The novel biological action of antimicrobial peptides via apoptosis induction. J Microbiol Biotechnol 22:1457–1466

    CAS  PubMed  Google Scholar 

  • Chu H-L, Yip B-S, Chen K-H, Yu H-Y, Chih Y-H, Cheng H-T, Chou Y-T, Cheng J-W (2015) Novel antimicrobial peptides with high anticancer activity and selectivity. PLoS One 10:e0126390

    PubMed  PubMed Central  Google Scholar 

  • Chumchalová J, Smarda J (2003) Human tumor cells are selectively inhibited by colicins. Folia Microbiol (Praha) 48:111–115

    Google Scholar 

  • Cintas LM, Rodriguez JM, Fernandez MF, Sletten K, Nes IF, Hernandez PE, Holo H (1995) Isolation and characterization of pediocin L50, a new bacteriocin from Pediococcus acidilactici with a broad inhibitory spectrum. Appl Environ Microbiol 61:2643–2648

    CAS  PubMed  PubMed Central  Google Scholar 

  • Coburn PS, Gilmore MS (2003) The Enterococcus faecalis cytolysin: a novel toxin active against eukaryotic and prokaryotic cells. Cell Microbiol 5(10):661–669

    CAS  PubMed  Google Scholar 

  • Coley WB (1910) The treatment of inoperable sarcoma by bacterial toxins (the mixed toxins of the Streptococcus erysipelas and the Bacillus prodigiosus). Proc R Soc Med 3:1–48

    CAS  PubMed  PubMed Central  Google Scholar 

  • Connor J, Bucana C, Fidler IJ, Schroit J (1989) Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer-leaflet lipid by prothrombinase complex formation. Proc Natl Acad Sci U S A 86:3184–3188

    CAS  PubMed  PubMed Central  Google Scholar 

  • Cornut G, Fortin C, Soulières D (2008) Antineoplastic properties of bacteriocins: revisiting potential active agents. Am J Clin Oncol 31:399–404

    CAS  PubMed  Google Scholar 

  • Cotter PD (2012) A bacteriocin perspective. Bioengineered 3:313–319

    PubMed  PubMed Central  Google Scholar 

  • Crowther GS, Baines SD, Todhunter SL, Freeman J, Chilton CH, Wilcox MH (2013) Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection. J Antimicrob Chemother 68:168–176

    CAS  PubMed  Google Scholar 

  • Cursino L, Šmarda J, Chartone-Souza E, Nascimento AMA (2002) Recent updated aspects of colicins of enterobacteriaceae. Braz J Microbiol 33:185–195

    CAS  Google Scholar 

  • Cursino L, Smajs D, Smarda J, Nardi RMD, Nicoli JR, Chartone-Souza E, Nascimento AMA (2006) Exoproducts of the Escherichia coli strain H22 inhibiting some enteric pathogens both in vitro and in vivo. J Appl Microbiol 100:821–829

    CAS  PubMed  Google Scholar 

  • Cutter CN, Siragusa GR (1998) Incorporation of nisin into a meat binding system to inhibit bacteria on beef surfaces. Lett Appl Microbiol 27:19–23

    CAS  PubMed  Google Scholar 

  • Dabour N, Zihler A, Kheadr E, Lacroix C, Fliss I (2009) In vivo study on the effectiveness of pediocin PA-1 and Pediococcus acidilactici UL5 at inhibiting Listeria monocytogenes. Int J Food Microbiol 133:225–233

    CAS  PubMed  Google Scholar 

  • Dang LH, Bettegowda C, Huso DL, Kinzler KW, Vogelstein B (2001) Combination bacteriolytic therapy for the treatment of experimental tumors. Proc NatlAcad Sci USA 98:15155–15160

    CAS  Google Scholar 

  • Dethlefsen L, Eckburg PB, Bik EM, Relman D (2006) Assembly of the human intestinal microbiota. Trends Ecol Evol 21:517–523

    PubMed  Google Scholar 

  • Dobrzyńska I, Szachowicz-Petelska B, Sulkowski S, Figaszewski Z (2005) Changes in electric charge and phospholipids composition in human colorectal cancer cells. Mol Cell Biochem 276:113–119

    PubMed  Google Scholar 

  • Domagala WKL (1980) Surface configuration of human tumor cells obtained by fine needle aspiration biopsy. Scan Electron Microsc 3:101–108

    Google Scholar 

  • Drider D, Fimland G, Héchard Y, McMullen LM, Prévost H (2006) The continuing story of class IIa bacteriocins. Microbiol Mol Biol Rev 70:564–582

    CAS  PubMed  PubMed Central  Google Scholar 

  • Duquesne S, Destoumieux-Garzón D (2007) Microcins, gene-encoded antibacterial peptides from enterobacteria. Nat Prod Rep 24:75005

    Google Scholar 

  • Elegado FB, Kim WJ, Kwon DY (1997) Rapid purification, partial characterization, and antimicrobial spectrum of the bacteriocin, Pediocin AcM, from Pediococcus acidilactici M. Int J Food Microbiol 37:1–11

    CAS  PubMed  Google Scholar 

  • Ennahar S, Aoude-Werner D, Sorokine O, Van Dorsselaer A, Bringel F, Hubert JC, Hasselmann C (1996) Production of pediocin AcH by Lactobacillus plantarum WHE 92 isolated from cheese. Appl Environ Microbiol 62:4381–4387

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ennahar S, Sashihara T, Sonomoto K, Ishizaki A (2000) Class IIa bacteriocins: biosynthesis, structure and activity. FEMS Microbiol Rev 24:85–106

    CAS  PubMed  Google Scholar 

  • Fadeel B, Xue D (2009) The ins and outs of phospholid asymmetry in the plasma membrane: roles in health and disease. Crit Rev Biochem Mol Biol 44:264–277

    CAS  PubMed  PubMed Central  Google Scholar 

  • Farkas-Himsley H, Cheung R (1976) Bacterial proteinaceous products (bacteriocins) as cytotoxic agents of neoplasia. Cancer Res 36:3561–3567

    CAS  PubMed  Google Scholar 

  • Farkas-Himsley H, Hill R, Rosen B, Arab S, Lingwood C a (1995) The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1. Proc Natl Acad Sci U S A 92:6996–7000

    CAS  PubMed  PubMed Central  Google Scholar 

  • Feldgarden M, Riley MA (1999) The phenotypic and fitness effects of colicin resistance in Escherichia coli K-12. Evolution (N Y) 53:1019–1027

    CAS  PubMed  Google Scholar 

  • Fernández L, Delgado S, Herrero H, Maldonado A, Rodríguez JM (2008) The bacteriocin nisin, an effective agent for the treatment of staphylococcal mastitis during lactation. J Hum Lact 24:311–316

    PubMed  Google Scholar 

  • Fialho AM, Salunkhe P, Manna S, Mahali S, Chakrabarty AM (2012) Glioblastoma multiforme: novel therapeutic approaches. ISRN Neurol 2012:1–10

    Google Scholar 

  • Fimland G, Johnsen L, Dalhus B, Nissen-Meyer J (2005) Pediocin-like antimicrobial peptides (class IIa bacteriocins) and their immunity proteins: biosynthesis, structure, and mode of action. J Pept Sci 11:688–696

    CAS  PubMed  Google Scholar 

  • Fons AG, Tuomo Karjalainen M (2000) Mechanisms of colonisation and colonisation resistance of the digestive tract part 2: bacteria/bacteria interactions. Microb Ecol Health Dis 12:240–246

    Google Scholar 

  • Fontana MBC, de Bastos MDCF, Brandelli A, Freire De Bastos MDC, Brandelli A (2006) Bacteriocins Pep5 and epidermin inhibit Staphylococcus epidermidis adhesion to catheters. Curr Microbiol 52:350–353

    CAS  PubMed  Google Scholar 

  • Frana TS, Carlson SA, Rauser DC, Jones BD, Fergen BJ, Griffith RW (2004) Effects of microcin 24-producing Escherichia coli on shedding and multiple-antimicrobial resistance of Salmonella enterica serotype Typhimurium in pigs. Am J Vet Res 65:1616–1620

    CAS  PubMed  Google Scholar 

  • Fuska J, Fuskova A, Smarda JMJ (1979) Effect of colicin E3 on leukemia cells P388 in vitro. Experientia 35:406–407

    CAS  PubMed  Google Scholar 

  • Gandhi NM, Morales A, Lamm DL (2013) Bacillus Calmette-Guérin immunotherapy for genitourinary cancer. BJU Int 112:288–297

    CAS  PubMed  Google Scholar 

  • Goldstein BP, Wei J, Greenberg K, Novick R (1998) Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model. J Antimicrob Chemother 42:277–278

    CAS  PubMed  Google Scholar 

  • Goto M, Yamada T, Kimbara K, Horner J, Newcomb M, Das Gupta TK, Chakrabarty a M (2003) Induction of apoptosis in macrophages by Pseudomonas aeruginosa azurin: tumour-suppressor protein p53 and reactive oxygen species, but not redox activity, as critical elements in cytotoxicity. Mol Microbiol 47:549–559

    CAS  PubMed  Google Scholar 

  • Grasemann H, Stehling F, Brunar H, Widmann R, Laliberte TW, Molina L, Döring G, Ratjen F (2007) Inhalation of Moli1901 in patients with cystic fibrosis. Chest 131:1461–1466

    CAS  PubMed  Google Scholar 

  • Gratia A (1925) Sur un remarquable example d’antagonisme entre deux souches de colibacille. Compt Rend Soc Biol 93(Cross reference):1040–1042

    Google Scholar 

  • Gray MW (2012) Mitochondrial evolution. Cold Spring Harb Perspect Biol 4:a011403

    PubMed  PubMed Central  Google Scholar 

  • Gray M, Burger G, Lang BF (2001) The origin and early evolution of mitochondria. Genome Biol 2: reviews 1018:1–1018

    Google Scholar 

  • Grover V, Kapoor A, Sehgal K, Kaur G (2016) Chronic inflammation and carcinogenesis—emerging role of chronic inflammatory periodontal disease. Cancer Res Front 2:200–225

    Google Scholar 

  • Gunther J (1991) Lantibiotics—ribosomally synthesized biologically active polypeptides containing sulfide bridges and α,β-didehydroamino acids. Angew Chem Int Ed 30:1051–1068

    Google Scholar 

  • Gupta DT (2002) Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer. Proc Natl Acad Sci U S A:14098–14103

  • Hammami R, Zouhir A, Ben Hamida J, Fliss I (2007) BACTIBASE: a new web-accessible database for bacteriocin characterization. BMC Microbiol 7:89

    PubMed  PubMed Central  Google Scholar 

  • Hammami R, Zouhir A, Le Lay C, Ben Hamida J, Fliss I (2010) BACTIBASE second release: a database and tool platform for bacteriocin characterization. BMC Microbiol 10:22

    PubMed  PubMed Central  Google Scholar 

  • Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70

    CAS  PubMed  Google Scholar 

  • Haugen HS, Kristiansen PE, Fimland G, Nissen-Meyer J (2008) Mutational analysis of the class IIa bacteriocin curvacin A and its orientation in target cell membranes. Appl Environ Microbiol 74:6766–6773

    CAS  PubMed  PubMed Central  Google Scholar 

  • Helbig S, Braun V (2011) Mapping functional domains of colicin M. J Bacteriol 193:815–821

    CAS  PubMed  Google Scholar 

  • Herr HW, Morales A (2008) History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story. J Urol 179:53–56

    PubMed  Google Scholar 

  • Hetz C, Bono MR, Barros LF, Lagos R (2002) Microcin E492, a channel-forming bacteriocin from Klebsiella pneumoniae, induces apoptosis in some human cell lines. Proc Natl Acad Sci U S A 99:2696–2701

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hillman JD, Mo J, McDonell E, Cvitkovitch D, Hillman CH (2007) Modification of an effector strain for replacement therapy of dental caries to enable clinical safety trials. J Appl Microbiol 102:1209–1219

    CAS  PubMed  Google Scholar 

  • Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2012, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/archive/csr/1975_2012/ Accessed 20 Aug 2018

  • Huang Y-B, Wang X-F, Wang H-Y, Liu Y, Chen Y (2011) Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework. Mol Cancer Ther 10:416–426

    CAS  PubMed  Google Scholar 

  • Ingham A, Ford M, Moore RJ, Tizard M (2003) The bacteriocin piscicolin 126 retains antilisterial activity in vivo. J Antimicrob Chemother 51:1365–1371

    CAS  PubMed  Google Scholar 

  • Jabés D, Brunati C, Candiani G, Riva S, Romanó G, Donadio S (2011) Efficacy of the new lantibiotic NAI-107 in experimental infections induced by multidrug-resistant gram-positive pathogens. Antimicrob Agents Chemother 55:1671–1676

    PubMed  PubMed Central  Google Scholar 

  • Jasniewski J, Cailliez-Grimal C, Chevalot I, Millière J-B, Revol-Junelles A-M (2009) Interactions between two carnobacteriocins Cbn BM1 and Cbn B2 from Carnobacterium maltaromaticum CP5 on target bacteria and Caco-2 cells. Food Chem Toxicol 47:893–897

    CAS  PubMed  Google Scholar 

  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249

    PubMed  Google Scholar 

  • Jeuken LJ, Ubbink M, Bitter JH, van Vliet P, Meyer-Klaucke W, Canters GW (2000) The structural role of the copper-coordinating and surface-exposed histidine residue in the blue copper protein azurin. J Mol Biol 299:737–755

    CAS  PubMed  Google Scholar 

  • Jeziorowski A, Gordon DM (2007) Evolution of microcin V and colicin Ia plasmids in Escherichia coli. J Bacteriol 189:7045–7052

    CAS  PubMed  PubMed Central  Google Scholar 

  • Jia L, Gorman GS, Coward LU, Noker PE, McCormick D, Horn TL, Harder JB, Muzzio M, Prabhakar B, Ganesh B, Das Gupta TK, Beattie CW (2011) Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination. Cancer Chemother Pharmacol 68:513–524

    CAS  PubMed  Google Scholar 

  • Johnson CL, Ridley H, Pengelly RJ, Salleh MZ, Lakey JH (2013) The unstructured domain of colicin N kills Escherichia coli. Mol Microbiol 89:84–95

    CAS  PubMed  PubMed Central  Google Scholar 

  • Johnstone SA, Gelmon K, Mayer LD, Hancock RE, Bally MB (2000) In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines. Anticancer Drug Des 15:151–160

    CAS  PubMed  Google Scholar 

  • Joo NE, Ritchie K, Kamarajan P, Miao D, Kapila YL (2012) Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Med 1:295–305

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kageyama M (1964) Studies of a pyocin. J Biochem 55:49–53

    CAS  PubMed  Google Scholar 

  • Kamarajan P, Hayami T, Matte B, Liu Y, Danciu T, Ramamoorthy A, Worden F, Kapila S, Kapila Y (2015) Nisin ZP, a bacteriocin and food preservative, inhibits head and neck cancer tumorigenesis and prolongs survival. PLoS One 10:e0131008

    PubMed  PubMed Central  Google Scholar 

  • Kang BS, Seo JG, Lee GS, Kim JH, Kim SY, Han YW, Kang H, Kim HO, Rhee JH, Chung MJ, Park YM (2009) Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acne, the causative agent in acne vulgaris, and its therapeutic effect. J Microbiol 47:101–109

    CAS  PubMed  Google Scholar 

  • Kaur S, Kaur S (2015) Bacteriocins as potential anticancer agents. Front Pharmacol 6:272

    PubMed  PubMed Central  Google Scholar 

  • Kawai K, Miyazaki J, Joraku A, Nishiyama H, Akaza H (2013) Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine. Cancer Sci 104:22–27

    CAS  PubMed  Google Scholar 

  • Kim R, Emi M, Tanabe K (2006) Role of mitochondria as the gardens of cell death. Cancer Chemother Pharmacol 57:545–553

    CAS  PubMed  Google Scholar 

  • Klener P (1999) Chemotherapy side effects and their management. Basic Clin Oncol 19:279–295 ST

    CAS  Google Scholar 

  • Kozłowska K, Nowak J, Kwiatkowski B, Cichorek M (1999) ESR study of plasmatic membrane of the transplantable melanoma cells in relation to their biological properties. Exp Toxicol Pathol 51:89–92

    PubMed  Google Scholar 

  • Kristiansen PE, Fimland G, Mantzilas D, Nissen-Meyer J (2005) Structure and mode of action of the membrane-permeabilizing antimicrobial peptide pheromone plantaricin A. J Biol Chem 280:22945–22950

    CAS  PubMed  Google Scholar 

  • de Kroon AI, Dolis D, Mayer A, Lill R, de Kruijff B (1997) Phospholipid composition of highly purified mitochondrial outer membranes of rat liver and Neurospora crassa. Is cardiolipin present in the mitochondrial outer membrane? Biochim Biophys Acta 1325:108–116

    PubMed  Google Scholar 

  • Kruis W (2004) Antibiotics and probiotics in inflammatory bowel disease. Aliment Pharmacol Ther 20(Suppl 4):75–78

    CAS  PubMed  Google Scholar 

  • Kruszewska D, Sahl H-G, Bierbaum G, Pag U, Hynes SO, Ljungh A (2004) Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J Antimicrob Chemother 54:648–653

    CAS  PubMed  Google Scholar 

  • Kumar B, Balgir PP, Kaur B, Garg N (2011) Cloning and expression of bacteriocins of Pediococcus spp.: a review. Arch Clin Microbiol 2:1–18

    Google Scholar 

  • de Kwaadsteniet M, Doeschate KT, Dicks LMT (2009) Nisin F in the treatment of respiratory tract infections caused by Staphylococcus aureus. Lett Appl Microbiol 48(1):65–70

  • Kwan JM, Fialho AM, Kundu M, Thomas J, Hong CS, Das Gupta TK, Chakrabarty AM (2009) Bacterial proteins as potential drugs in the treatment of leukemia. Leuk Res 33:1392–1399

    CAS  PubMed  Google Scholar 

  • Lagos R, Wilkens M, Vergara C, Cecchi X, Monasterio O (1993) Microcin E492 forms ion channels in phospholipid bilayer membranes. FEBS Lett 321:145–148

    CAS  PubMed  Google Scholar 

  • Lagos R, Tello M, Mercado G, García V, Monasterio O (2009) Antibacterial and antitumorigenic properties of microcin E492, a pore-forming bacteriocin. Curr Pharm Biotechnol 10:74–85

    CAS  PubMed  Google Scholar 

  • Lao Y, Wang X, Xu N, Zhang H, Xu H (2014) Application of proteomics to determine the mechanism of action of traditional Chinese medicine remedies. J Ethnopharmacol 155(1):1–8

    CAS  PubMed  Google Scholar 

  • Laverty G, Gilmore B (2014) Cationic antimicrobial peptide cytotoxicity. SOJ Microbiol Infect Dis 2:1

    Google Scholar 

  • Lee DG, Hahm K-S, Park Y, Kim H-Y, Lee W, Lim S-C, Seo Y-K, Choi C-H (2005) Functional and structural characteristics of anticancer peptide Pep27 analogues. Cancer Cell Int 5:21

    PubMed  PubMed Central  Google Scholar 

  • Leisner JJ, Greer GG, Stiles ME (1996) Control of beef spoilage by a sulfide-producing Lactobacillus sake strain with bacteriocinogenic Leuconostoc gelidum UAL187 during anaerobic storage at 2 degrees C. Appl Environ Microbiol 62:2610–2614

    CAS  PubMed  PubMed Central  Google Scholar 

  • Letzel A, Pidot SJ, Hertweck C (2014) Genome mining for ribosomally synthesized and post-translationally modified peptides (RiPPs) in anaerobic bacteria. BMC Genomics 15:983

    PubMed  PubMed Central  Google Scholar 

  • Lopez FE, Vincent PA, Zenoff AM, Salomón RA, Farías RN (2007) Efficacy of microcin J25 in biomatrices and in a mouse model of Salmonella infection. J Antimicrob Chemother 59:676–680

    CAS  PubMed  Google Scholar 

  • de Lorenzo V (1984) Isolation and characterization of microcin E492 from Klebsiella pneumoniae. Arch Microbiol 139:72–75

    PubMed  Google Scholar 

  • de Lorenzo V, Pugsley AP (1985) Microcin E492, a low-molecular-weight peptide antibiotic which causes depolarization of the Escherichia coli cytoplasmic membrane. Antimicrob Agents Chemother 27:666–669

    PubMed  PubMed Central  Google Scholar 

  • Mader JS, Hoskin DW (2006) Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Investig Drugs 15:933–946

    CAS  PubMed  Google Scholar 

  • Maher S, McClean S (2006) Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro. Biochem Pharmacol 71:1289–1298

    CAS  PubMed  Google Scholar 

  • Maletzki C, Gock M, Klier U, Klar E, Linnebacher M (2010) Bacteriolytic therapy of experimental pancreatic carcinoma. World J Gastroenterol 16:3546–3552

    PubMed  PubMed Central  Google Scholar 

  • Manno S, Takakuwa Y, Mohandas N (2002) Identification of a functional role for lipid asymmetry in biological membranes: phosphatidylserine-skeletal protein interactions modulate membrane stability. Proc Natl Acad Sci U S A 99:1943–1948

    CAS  PubMed  PubMed Central  Google Scholar 

  • Manosroi A, Khanrin P, Lohcharoenkal W, Werner RG, Gtz F, Manosroi W, Manosroi J (2010) Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int J Pharm 392:304–310

    CAS  PubMed  Google Scholar 

  • Mantovani HC, Hu H, Worobo RW, Russell JB (2002) Bovicin HC5, a bacteriocin from Streptococcus bovis HC5. Microbiology 148:3347–3352

    CAS  PubMed  Google Scholar 

  • Martín R, Escobedo S, Martín C, Crespo A, Quiros LMSJ (2015) Surface glycosaminoglycans protect eukaryotic cells against membrane-driven peptide bacteriocins. Antimicrob Agents Chemother 59:677–681

    PubMed  Google Scholar 

  • Mehta RR, Hawthorne M, Peng X, Shilkaitis A, Mehta RG, Beattie CW, Das Gupta TK (2010) A 28-amino-acid peptide fragment of the cupredoxin azurin prevents carcinogen-induced mouse mammary lesions. Cancer Prev Res 3:1351–1360

    CAS  Google Scholar 

  • Mehta RR, Yamada T, Taylor BN, Christov K, King ML, Majumdar D, Lekmine F, Tiruppathi C, Shilkaitis A, Bratescu L, Green A, Beattie CW, Das Gupta TK (2011) A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt. Angiogenesis 14:355–369

    CAS  PubMed  Google Scholar 

  • Metlitskaya AZ, Katrukha GS, Shashkov AS, Zaitsev DA, Egorov TA, Khmel IA (1995) Structure of microcin C51, a new antibiotic with a broad spectrum of activity. FEBS Lett 357:235–238

    CAS  PubMed  Google Scholar 

  • Michaud DS, Izard J (2014) Microbiota, oral microbiome, and pancreatic cancer. Cancer J 20:203–206

    CAS  PubMed  PubMed Central  Google Scholar 

  • Michel-Briand Y, Baysse C (2002) The pyocins of Pseudomonas aeruginosa. Biochimie 84:499–510

    CAS  PubMed  Google Scholar 

  • Mohimani H, Kersten RD, Liu WT, Wang M, Purvine SO, Wu S, Brewer HM, Pasa-Tolic L, Bandeira N, Moore BS, Pevzner PA, Dorrestein PC (2014) Automated genome mining of ribosomal peptide natural products. ACS Chem Biol 9:1545–1551

    CAS  PubMed  PubMed Central  Google Scholar 

  • Moll GN, Konings WN, Driessena JM (1999) Bacteriocins: mechanism of membrane insertion and pore formation. Antonie van Leeuwenhoek Int J Gen Mol Microbiol 76:185–198

    CAS  Google Scholar 

  • Mota-Meira M, Morency H, Lavoie MC (2005) In vivo activity of mutacin B-Ny266. J Antimicrob Chemother 56:869–871

    CAS  PubMed  Google Scholar 

  • Murinda SE, Rashid KARR (2003) In vitro assessment of the cytotoxicity of nisin, pediocin, and selected colicins on simian virus 40-transfected human colon and Vero monkey kidney cells with trypan blue staining viability assays. J Food Prot 66:847–853

    CAS  PubMed  Google Scholar 

  • Nakazawa I, Iwaizumi M (1989) A role of the cancer cell membrane fluidity in the cancer metastases: an ESR study. Tohoku J Exp Med 157:193

    CAS  PubMed  Google Scholar 

  • Nes IF, Holo H (2000) Class II antimicrobial peptides from lactic acid bacteria. Biopolymers 55:50–61

    CAS  PubMed  Google Scholar 

  • Nguyen CNVD (2016) Discovery of azurin-like anticancer bacteriocins from human gut microbiome through homology modeling and molecular docking against the tumor suppressor p53. Biomed Res Int 2016:12

    Google Scholar 

  • Nuñez M, Rodríguez JL, García E, Gaya P, Medina M (1997) Inhibition of Listeria monocytogenes by enterocin 4 during the manufacture and ripening of Manchego cheese. J Appl Microbiol 83:671–677

    PubMed  Google Scholar 

  • O’Shea EF, O’Connor PM, Cotter PD, Ross RP, Hill C (2010) Synthesis of trypsin-resistant variants of the listeria-active bacteriocin salivaricin P. Appl Environ Microbiol 76:5356–5362

    PubMed  PubMed Central  Google Scholar 

  • Op den Kamp J (1979) Lipid asymmetry in membranes. Annu Rev Biochem 48:47–71

    Google Scholar 

  • Oppegård C, Fimland G, Thorbaek L, Nissen-Meyer J (2007) Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis. Appl Environ Microbiol 73:2931–2938

    PubMed  PubMed Central  Google Scholar 

  • Oppegård C, Rogne P, Kristiansen PE, Nissen-Meyer J (2010) Structure analysis of the two-peptide bacteriocin lactococcin G by introducing D-amino acid residues. Microbiology 156:1883–1889

    PubMed  Google Scholar 

  • Paiva AD, de Oliveira MD, de Paula SO, Baracat-Pereira MC, Breukink E, Mantovani HC (2012) Toxicity of bovicin HC5 against mammalian cell lines and the role of cholesterol in bacteriocin activity. Microbiol (United Kingdom) 158:2851–2858

    CAS  Google Scholar 

  • Papagianni M (2003) Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications. Biotechnol Adv 21:465–499

    CAS  PubMed  Google Scholar 

  • Patyar S, Joshi R, Byrav DSP, Prakash MB, Das BK (2010) Bacteria in cancer therapy: a novel experimental strategy. J Biomed Sci 17:21

    CAS  PubMed  PubMed Central  Google Scholar 

  • Perez RH, Zendo T, Sonomoto K (2014) Novel bacteriocins from lactic acid bacteria (LAB): various structures and applications. Microb Cell Factories 13(Suppl 1):S3

    Google Scholar 

  • Pieterse R, Todorov SD (2010) Bacteriocins: exploring alternatives to antibiotics in mastitis treatment. Braz J Microbiol 41:542–562

    PubMed  PubMed Central  Google Scholar 

  • Piper C, Hill C, Cotter PD, Ross RP (2011) Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z. Microb Biotechnol 4:375–382

    CAS  PubMed  PubMed Central  Google Scholar 

  • Piper C, Casey PG, Hill C, Cotter PD, Ross RP (2012) The lantibiotic Lacticin 3147 prevents systemic spread of Staphylococcus aureus in a murine infection model. Int J Microbiol 2012:806230. https://doi.org/10.1155/2012/806230

    Google Scholar 

  • Pons AM, Delalande F, Duarte M, Benoit S, Lanneluc I, Sablé S, Van Dorsselaer A, Cottenceau G (2004) Genetic analysis and complete primary structure of microcin L. Antimicrob Agents Chemother 48:505–513

    CAS  PubMed  PubMed Central  Google Scholar 

  • Porta C, Cosmai L, Gallieni M, Pedrazzoli P, Malberti F (2015) Renal effects of targeted anticancer therapies. Nat Rev Nephrol 11:354–370

    CAS  PubMed  Google Scholar 

  • Punj V, Bhattacharyya S, Saint-Dic D, Vasu C, E a C, Graves J, Yamada T, Constantinou AI, Christov K, White B, Li G, Majumdar D, Chakrabarty AM, Das Gupta TK (2004) Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer. Oncogene 23:2367–2378

    CAS  PubMed  Google Scholar 

  • Ramachandran S, Mandal M (2011) Induction of apoptosis of azurin synthesized from P. aeruginosa MTCC 2453 against Dalton’s lymphoma ascites model. Biomed Pharmacother 65:461–466

    CAS  PubMed  Google Scholar 

  • Reddy KVR, Aranha C, Gupta SM, Yedery RD (2004) Evaluation of antimicrobial peptide nisin as a safe vaginal contraceptive agent in rabbits: in vitro and in vivo studies. Reprod 128:117–126

    CAS  Google Scholar 

  • Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon ATR (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354:635–639

    CAS  PubMed  Google Scholar 

  • Ren J, Hamada J, Okada F, Takeichi N, Morikawa K, Hosokawa MKH (1990) Correlation between the presence of microvilli and the growth or metastatic potential of tumor cells. Jpn J Cancer Res 81:920–926

    CAS  PubMed  PubMed Central  Google Scholar 

  • Riedl SJ, Pasquale EB (2015) Targeting the Eph system with peptides and peptide conjugates. Curr Drug Targets 16:1031–1047

    CAS  PubMed  PubMed Central  Google Scholar 

  • Riedl S, Zweytick D, Lohner K (2011) Membrane-active host defense peptides—challenges and perspectives for the development of novel anticancer drugs. Chem Phys Lipids 164:766–781

    CAS  PubMed  PubMed Central  Google Scholar 

  • Riley MA, Wertz JE (2002) Bacteriocins: evolution, ecology, and application. Annu Rev Microbiol 56:117–137

    CAS  PubMed  Google Scholar 

  • Rothman JE, Lenard J (1977) Membrane asymmetry. Science 195:743–753

    CAS  PubMed  Google Scholar 

  • Ryan MP, Meaney WJ, Ross RP, Hill C (1998) Evaluation of lacticin 3147 and a teat seal containing this bacteriocin for inhibition of mastitis pathogens. Appl Environ Microbiol 64:2287–2290

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sahl H (2000) New insights into the mechanism of action of lantibiotics—diverse. J Antimicrob Chemother 46:1–6

    PubMed  Google Scholar 

  • Saito H, Watanabe T (1979) Effect of a bacteriocin produced by Mycobacterium smegmatis on growth of cultured tumor and normal cells. Cancer Res 39:5114–5117

    CAS  PubMed  Google Scholar 

  • Salvucci E, Saavedra L, Hebert EM, Haro C, Sesma F (2012) Enterocin CRL35 inhibits Listeria monocytogenes in a murine model. Foodborne Pathog Dis 9:68–74

    CAS  PubMed  Google Scholar 

  • Sand SL, Oppegård C, Ohara S, Iijima T, Naderi S, Blomhoff HK, Nissen-Meyer J, Sand O (2010) Plantaricin A, a peptide pheromone produced by Lactobacillus plantarum, permeabilizes the cell membrane of both normal and cancerous lymphocytes and neuronal cells. Peptides 31:1237–1244

    CAS  PubMed  Google Scholar 

  • Sand SL, Nissen-Meyer J, Sand O, Haug TM (2013) Plantaricin A, a cationic peptide produced by Lactobacillus plantarum, permeabilizes eukaryotic cell membranes by a mechanism dependent on negative surface charge linked to glycosylated membrane proteins. Biochim Biophys Acta Biomembr 1828:249–259

    CAS  Google Scholar 

  • Schenkel LC, Bakovic M (2014) Formation and regulation of mitochondrial membranes. Int J Cell Biol 2014:709828

    PubMed  PubMed Central  Google Scholar 

  • Schved F, Lalazar A, Henis Y, Juven BJ (1993) Purification, partial characterization and plasmid linkage of pediocin SJ1, a bacteriocin produced by Pediococcus acidilactici. J Appl Bacteriol 74:67–77

    CAS  PubMed  Google Scholar 

  • Schwartz B, Bresalier RS, Kim YS (1992) The role of mucin in colon-cancer metastasis. Int J Cancer 52:60–65

    CAS  PubMed  Google Scholar 

  • Settanni L, Corsetti A (2008) Application of bacteriocins in vegetable food biopreservation. Int J Food Microbiol 121:123–138

    CAS  PubMed  Google Scholar 

  • Shaikh F, Abhinand P, Ragunath P (2012) Identification & characterization of Lactobacillus salavarius bacteriocins and its relevance in cancer therapeutics. Bioinformation 8:589–594

    PubMed  PubMed Central  Google Scholar 

  • Shin JM, Gwak JW, Kamarajan P, Fenno JC, Rickard AH, Kapila YL (2016) Biomedical applications of nisin. J Appl Microbiol 120:1449–14465

    CAS  PubMed  PubMed Central  Google Scholar 

  • Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65:5–29

    PubMed  Google Scholar 

  • Silkin L, Hamza S, Kaufman S, Cobb SL, Vederas JC (2008) Spermicidal bacteriocins: lacticin 3147 and subtilosin A. Bioorg Med Chem Lett 18:3103–3106

    CAS  PubMed  Google Scholar 

  • Singh PK, Solanki V, Sharma S, Thakur KG, Krishnan B, Korpole S (2014) The intramolecular disulfide-stapled structure of laterosporulin, a class IId bacteriocin, conceals a human defensin-like structural module. FEBS J 282:203–214

    PubMed  Google Scholar 

  • Smarda JKJ (1987) Cytotoxic effects of colicins E1-E5 and K on hamster fibroblasts. Folia Microbiol (Praha) 32:133–136

    CAS  Google Scholar 

  • Smarda J, Smajs D (1998) Colicins—exocellular lethal proteins of Escherichia coli. Folia Microbiol (Praha) 43:563–582

    CAS  Google Scholar 

  • Smarda J, Obdrzalek V, Taborsky I, Mach J (1978) The cytotoxic and cytocidal effect of colicin E3 on mammalian tissue cells. Folia Microbiol (Praha) 23:272–277

    CAS  Google Scholar 

  • Smarda J, Oravec C (1989) Cytocidal effect of bacteriocin on lymphoma cells. Akt Klin Onkol 21:209–212

  • Smarda J, Fialova M, Šmarda J (2001) Cytotoxic effects of colicins E1 and E3 on v-myb-transformed chicken monoblasts. Folia Biol (Praha) 47:11–13

    CAS  Google Scholar 

  • Smith L, Hillman JD (2008) Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics. Curr Opin Microbiol 11:401–408

    CAS  PubMed  PubMed Central  Google Scholar 

  • Smolarczyk R, Cichoń T, Kamysz W, Głowala-Kosińska M, Szydło A, Szultka L, Sieroń AL, Szala S (2010) Anticancer effects of CAMEL peptide. Lab Investig 90:940–952

    CAS  PubMed  Google Scholar 

  • Sok M, Sentjurc M, Schara M (1999) Membrane fluidity characteristics of human lung cancer. Cancer Lett 139:215–220

    CAS  PubMed  Google Scholar 

  • van Staden D, Brand M, Dicks LMT (2012) Nisin F-loaded brushite bone cement prevented the growth of Staphylococcus aureus in vivo. J Appl Microbiol 112:831–840

    PubMed  Google Scholar 

  • Steiner I, Errhalt P, Kubesch K, Hubner M, Holy M, Bauer M, Muller M, Hinterberger S, Widmann R, Mascher D, Freissmuth M, Kneussl M (2008) Pulmonary pharmacokinetics and safety of nebulized duramycin in healthy male volunteers. Naunyn Schmiedeberg's Arch Pharmacol 378:323–333

    CAS  Google Scholar 

  • Stern NJ, E a S, Eruslanov BV, Perelygin VV, Mitsevich EV, Mitsevich IP, Pokhilenko VD, Levchuk VP, Svetoch OE, Seal BS (2006) Isolation of a Lactobacillus salivarius strain and purification of its bacteriocin, which is inhibitory to Campylobacter jejuni in the chicken gastrointestinal system. Antimicrob Agents Chemother 50:3111–3116

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sun L, Song H, Zheng W (2015) Improvement of antimicrobial activity of pediocin PA-1 by site-directed mutagenesis in C-terminal domain. Protein Pept Lett (11):1007–1012

    CAS  Google Scholar 

  • Sung WS, Park Y, Choi C-H, Hahm K-S, Lee DG (2007) Mode of antibacterial action of a signal peptide, Pep27 from Streptococcus pneumoniae. Biochem Biophys Res Commun 363:806–810

    CAS  PubMed  Google Scholar 

  • Sutyak KE, Anderson RA, Dover SE, Feathergill KA, Aroutcheva AA, Faro S, Chikindas ML (2008) Spermicidal activity of the safe natural antimicrobial peptide subtilosin. Infect Dis Obstet Gynecol 2008

  • Turovskiy Y, Ludescher RD, Aroutcheva AA, Faro S, Chikindas ML (2009) Lactocin 160, a bacteriocin produced by vaginal Lactobacillus rhamnosus, targets cytoplasmic membranes of the vaginal pathogen, Gardnerella vaginalis. Probiotics Antimicrob Proteins 1:67–74

    CAS  PubMed  PubMed Central  Google Scholar 

  • Utsugi T, Schroita J, Connor J, Bucana CD, Fidler IJ (1991) Elevated expression of phosphatidylserine in the outer-membrane leaflet of human tumor-cells and recognition by activated human blood monocytes. Cancer Res 51:3062–3066

    CAS  PubMed  Google Scholar 

  • Vassiliadis G, Destoumieux-Garzón D, Lombard C, Rebuffat S, Peduzzi J (2010) Isolation and characterization of two members of the siderophore-microcin family, microcins M and H47. Antimicrob Agents Chemother 54:288–297

    CAS  PubMed  Google Scholar 

  • Vaucher R, Teixeira ML, Brandelli A (2010) Investigation of the cytotoxicity of antimicrobial peptide P40 on eukaryotic cells. Curr Microbiol 60:1–5

    CAS  PubMed  Google Scholar 

  • Verkleija J, Zwaal RF, Roelofsen B, Comfurius P, Kastelijn D, van Deenen LL (1973) The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim Biophys Acta 323:178–193

    Google Scholar 

  • Vignolo G, Fadda S, de Kairuz MN, Holgado d R, Oliver G (1996) Control of Listeria monocytogenes in ground beef by “Lactocin 705”, a bacteriocin produced by Lactobacillus casei CRL 705. Int J Food Microbiol 29:397–402

    CAS  PubMed  Google Scholar 

  • Villarante KI, Elegado FB, Iwatani S, Zendo T, Sonomoto K, de Guzman EE (2011) Purification, characterization and in vitro cytotoxicity of the bacteriocin from Pediococcus acidilactici K2a2-3 against human colon adenocarcinoma (HT29) and human cervical carcinoma (HeLa) cells. World J Microbiol Biotechnol 27:975–980

    CAS  Google Scholar 

  • Walsh CJ, Guinane CM, Hill C, Ross RP, O’Toole PW, Cotter PD (2015) In silico identification of bacteriocin gene clusters in the gastrointestinal tract, based on the Human Microbiome Project’s reference genome database. BMC Microbiol 15:183

    PubMed  PubMed Central  Google Scholar 

  • Wang C, Tian L-L, Li S, Li H-B, Zhou Y, Wang H, Yang Q-Z, Ma L-J, Shang D-J (2013) Rapid cytotoxicity of antimicrobial peptide tempoprin-1CEa in breast cancer cells through membrane destruction and intracellular calcium mechanism. PLoS One 8:e60462

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wang G, Manns DC, Churey JJ, Worobo RW (2014) Development of a homologous expression system for and systematic site-directed mutagenesis analysis of thurincin H, a bacteriocin produced by Bacillus thuringiensis SF361. Appl Environ Microbiol 80:3576–3584

    PubMed  PubMed Central  Google Scholar 

  • Wiemann B, Starnes CO (1994) Coley’s toxins, tumor necrosis factor and cancer research: a historical perspective. Pharmacol Ther 64:529–564

    CAS  PubMed  Google Scholar 

  • Wilson KA, Kalkum M, Ottesen J, Yuzenkova J, Chait BT, Landick R, Muir T, Severinov K, Darst SA (2003) Structure of microcin J25, a peptide inhibitor of bacterial RNA polymerase, is a lassoed tail. J Am Chem Soc 125:12475–12483

    CAS  PubMed  Google Scholar 

  • Wriessnegger T, Leitner E, Belegratis MR, Ingolic E, Daum G (2009) Lipid analysis of mitochondrial membranes from the yeast Pichia pastoris. Biochim Biophys Acta 1791:166–172

    CAS  PubMed  Google Scholar 

  • Wu J, Hu S, Cao L (2007) Therapeutic effect of nisin Z on subclinical mastitis in lactating cows. Antimicrob Agents Chemother 51:3131–3135

    CAS  PubMed  PubMed Central  Google Scholar 

  • Yamada T, Goto M, Punj V, Zaborina O, Kimbara K, Das Gupta TK, Chakrabarty AM (2002) The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53. Infect Immun 70:7054–7062

    CAS  PubMed  PubMed Central  Google Scholar 

  • Yamada T, Fialho AM, Punj V, Bratescu L, Das Gupta TK, Chakrabarty AM (2005) Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity. Cell Microbiol 7:1418–1431

    CAS  PubMed  Google Scholar 

  • Yamada T, Mehta RR, Lekmine F, Christov K, King ML, Majumdar D, Shilkaitis A, Green A, Bratescu L, Beattie CW, Das Gupta TK (2009) A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells. Mol Cancer Ther 8:2947–2958

    CAS  PubMed  Google Scholar 

  • Yamada T, Christov K, Shilkaitis a, Bratescu L, Green a, Santini S, Bizzarri a R, Cannistraro S, Gupta TKD, Beattie CW (2013) P28, a first in class peptide inhibitor of Cop1 binding to P53. Br J Cancer 108:2495–2504

    CAS  PubMed  PubMed Central  Google Scholar 

  • Yang DS, Miao XD, Ye ZM, Feng J, Xu RZ, Huang X, Ge FF (2005) Bacterial redox protein azurin induce apoptosis in human osteosarcoma U2OS cells. Pharmacol Res 52:413–421

    CAS  PubMed  Google Scholar 

  • Ye JS, Zheng XJ, Leung KW, Chen HM, Sheu FS (2004) Induction of transient ion channel-like pores in a cancer cell by antibiotic peptide. J Biochem 136:255–259

    CAS  PubMed  Google Scholar 

  • Yoon WH, Park HD, Lim K, Hwang BD (1996) Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells. Biochem Biophys Res Commun 222:694–699

    CAS  PubMed  Google Scholar 

  • Zaborina O, Dhiman N, Chen ML, Kostal J, Holder IA, Chakrabarty AM (2000) Secreted products of a nonmucoid Pseudomonas aeruginosa strain induce two modes of macrophage killing: external-ATP-dependent, P2Z-receptor-mediated necrosis and ATP-independent, caspase-mediated apoptosis. Microbiol 146:2521–2530

    CAS  Google Scholar 

  • Zeisig R, Koklic T, Wiesner B, Fichtner I, Sentjurc M (2007) Increase in fluidity in the membrane of MT3 breast cancer cells correlates with enhanced cell adhesion in vitro and increased lung metastasis in NOD/SCID mice. Arch Biochem Biophys 459:98–106

    CAS  PubMed  Google Scholar 

  • Zhao H, Sood R, Jutila A, Bose S, Fimland G, Nissen-Meyer J, Kinnunen PKJ (2006) Interaction of the antimicrobial peptide pheromone plantaricin A with model membranes: implications for a novel mechanism of action. Biochim Biophys Acta Biomembr 1758:1461–1474

    CAS  Google Scholar 

  • Zhao J, Hao X, Liu D, Huang Y, Chen Y (2015) In vitro characterization of the rapid cytotoxicity of anticancer peptide HPRP-A2 through membrane destruction and intracellular mechanism against gastric cancer cell lines. PLoS One 10:e0139578

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MTCC and Gene Bank, CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, India

    Piyush Baindara & Suresh Korpole

  2. Dr. HS Judge Dental Institute and Hospital, Punjab University, Sector 25, Chandigarh, 160014, India

    Vishakha Grover

Authors
  1. Piyush Baindara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suresh Korpole
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vishakha Grover
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vishakha Grover.

Ethics declarations

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baindara, P., Korpole, S. & Grover, V. Bacteriocins: perspective for the development of novel anticancer drugs. Appl Microbiol Biotechnol 102, 10393–10408 (2018). https://doi.org/10.1007/s00253-018-9420-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00253-018-9420-8

Keywords

Search

Navigation